Dehydroepiandrosterone 100 and 400 mg ( DrugBank: Dehydroepiandrosterone )

1 disease

ID	Disease name (Link within this page)	Number of trials
113	Muscular dystrophy	1

113. Muscular dystrophy

Clinical trials : 646 / Drugs : 471 - (DrugBank : 105) / Drug target genes : 59 - Drug target pathways : 170

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00167609 (ClinicalTrials.gov)	November 2004	10/9/2005	Efficacy and Safety of DHEA for Myotonic Dystrophy	Phase 3 Study of Oral Dehydroepiandrosterone (DHEA) in Adults With Myotonic Dystrophy	Myotonic Dystrophy	Drug: dehydroepiandrosterone 100 and 400 mg	University of Versailles	Association Française contre les Myopathies (AFM), Paris;AP-HP	Completed	18 Years	70 Years	Both	75	Phase 2/Phase 3	France

First Previous1Next Last